Cardiac Ablation Market to Reach $8.6 Billion, Globally, by 2033 at 9.9% CAGR: Allied Market Research

PORTLAND, IL, UNITED STATES, December 17, 2024 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Cardiac Ablation Market by Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, and Others), Approach (Catheter-based and Open/Surgical), Application (Atrial Fibrillation & Flutter, Tachycardia, and Others), and End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the cardiac ablation market was valued at $3.6 billion in 2023, and is estimated to reach $8.6 billion by 2033, growing at a CAGR of 9.9% from 2024 to 2033.

Request Sample of the Report on Cardiac Ablation Market 2033 - https://www.alliedmarketresearch.com/request-sample/A296512

Prime Determinants of Growth

Patients and healthcare providers are increasingly opting for minimally invasive procedures due to their benefits, including shorter recovery times, reduced hospital stays, and lower complication rates. Cardiac ablation fits this trend, contributing to its growing popularity. Innovations in ablation technologies, such as the development of cryoablation and laser ablation, have improved the safety and efficacy of cardiac ablation. These advancements have broadened the range of conditions that can be treated, attracting more healthcare providers to use these techniques.

The continuous evolution of ablation technology, including the integration of robotics and advanced imaging, offers opportunities to develop more precise and effective procedures. These innovations can drive market growth by expanding the range of treatable conditions and improving patient outcomes. Partnerships between medical device companies, healthcare providers, and research institutions can accelerate innovation and market penetration. These collaborations can lead to the development of new techniques, shared expertise, and expanded market reach.

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A296512

Based on the product, the radiofrequency (RF) ablators sub-segment held the highest market share in 2023.

Cardiac arrhythmias, such as atrial fibrillation (AF), are on the rise, largely due to aging populations and lifestyle factors like obesity, stress, and hypertension. RF ablation has become a common treatment for arrhythmias, providing a less invasive alternative to open-heart surgery. As the incidence of arrhythmias increases, so does the demand for RF ablation. Recent advancements in RF technology, including improved catheter design, enhanced navigation systems, and integrated imaging techniques, have increased the accuracy and safety of RF ablation. These technological developments have broadened the range of treatable conditions and improved patient outcomes, further driving adoption.

Based on the approach, the catheter-based sub-segment held the highest market share in 2023.

This procedure is commonly employed to treat atrial fibrillation and various other cardiovascular diseases. According to the Heart and Stroke Foundation, about 25% of all strokes in people over the age of 40 are caused by atrial fibrillation, highlighting the high incidence of this condition.

Based on the application, the atrial fibrillation & flutter sub-segment held the highest market share in 2023.

The prevalence of atrial fibrillation and atrial flutter is increasing globally, partly due to aging populations and lifestyle-related risk factors such as obesity, hypertension, diabetes, and heart disease. As more people are diagnosed with these arrhythmias, the demand for cardiac ablation as a treatment option grows. Recent advancements in ablation technology have improved the safety and effectiveness of procedures used to treat atrial fibrillation and flutter. Technologies like cryoablation, laser ablation, and advanced radiofrequency ablation have contributed to better outcomes and fewer complications, making cardiac ablation a more attractive option for both patients and healthcare providers.

Based on the end use, the hospitals sub-segment held the highest market share in 2023.

Hospitals typically have comprehensive infrastructure and resources to support complex cardiac procedures like ablation. This includes specialized operating rooms, advanced imaging systems, monitoring equipment, and emergency response capabilities. These facilities attract patients and encourage hospitals to offer more ablation services. Hospitals often employ highly trained cardiac electrophysiologists, interventional cardiologists, and specialized nursing staff. This concentration of expertise allows hospitals to perform a high volume of cardiac ablation procedures, boosting the segment's growth.

Based on region, North America held the highest market share in terms of revenue in 2023

The aging population in North America has led to an increased incidence of age-related diseases, including atrial fibrillation and other cardiac conditions. As the elderly population grows, the demand for ablation procedures to treat these conditions rises accordingly. Patients and healthcare providers are increasingly opting for minimally invasive procedures due to their shorter recovery times, reduced complications, and lower costs compared to traditional surgery. Ablation methods fit this trend, leading to a higher adoption rate in the market. Favorable reimbursement policies in the United States and Canada contribute to the growth of the ablation market. These policies ensure that ablation procedures are covered by insurance, reducing the financial burden on patients and encouraging greater use of these treatments.

Key in the Players

Abbott Laboratories

Medtronic

Biosense Webster (Johnson & Johnson)

Angiodynamics

Boston Scientific Corporation

Atricure

Japan Lifeline

Teleflex Incorporated

St. Jude Medical Inc

Lepu Medical Technology (Beijing) Co., Ltd

MicroPort Scientific Corporation

The report provides a detailed analysis of these key players in the global cardiac ablation market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A296512

Recent Developments

In October 2021, Boston Scientific signed a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, with closing adjustments to be made as necessary.

The acquisition is set to enhance Boston Scientific's electrophysiology and structural heart product lines by incorporating the radiofrequency (RF) NRG and VersaCross Transseptal Platforms, along with a range of guidewires, sheaths, and dilators used for accessing the left heart.

The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X